• 검색 결과가 없습니다.

Risk Factors for Fatal Hemoptysis after Concurrent Chemoradiation Therapy in Patients with Non-Small Cell Lung Carcinoma

N/A
N/A
Protected

Academic year: 2021

Share "Risk Factors for Fatal Hemoptysis after Concurrent Chemoradiation Therapy in Patients with Non-Small Cell Lung Carcinoma"

Copied!
6
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table  1.  Clinical  characteristics  of  the  patients  that  presented  with  fatal  hemoptysis
Table  2.  Incidence  of  fatal  hemoptysis  according  to  clinical  parameters

참조

관련 문서

For my study, this being diagnosed with prostate cancer receiving treatment in patients with complementary and alternative therapies for their experience

 Although van der Waals equation is still less accurate at high

Although visceral fat adiposity has known to be associated with clinical, pathologic, and oncologic outcomes in patients with colorectal cancer (CRC), the

• Phase II clinical trials of PI3Kδ inhibitor (idelalisib) showed dramatic response in patients with previously treated indolent non-hodgkin’s

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable

Patients with breast cancer; ovarian cancer; renal cell carcinoma; pancreatic neuroendocrine cancer; colorectal cancer; head and neck cancer; non-small cell lung

Method We obtained blood samples from 49 patients who underwent surgical treatment for esophageal squamous cell cancer (ESCC) We performed ctDNA analysis with

period was prolonged unavoidably, (3) by explaining the risk factors associated with the failure to patients honestly, and subsequently performing